HCPLive

Multiple Sclerosis

Condition Resources
Make sure to bookmark and check back regularly for the most up-to-date multiple sclerosis resources.

Articles

Leukoencephalopathy Risk Factors ID'd for MS Drug
Multiple sclerosis patients taking natalizumab are at higher risk of developing progressive multifocal leukoencephalopathy (PML) if they are positive for the anti-JC virus antibodies, have been treated with immunosuppressants, and have been treated with natalizumab for longer periods.
Sign up for HCPLive eNewsletters
*Firstname:
*Lastname:
*Email:
*Practice Type:

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.
 




Become a Member